Table 9. The percentages of alterations in CAP2, CAP1, CFL1, CFL2, DSTN, ACTB, and ACTG1 genes.

Cancer	ACTB	ACTG1	CAP1	CAP2	CFL1	CFL2	DSTN
NEPC	21%	2.6%	13%	19%	30%	21%	19%
Pancrease	17%	10%	2.8%	4%	10%	5%	4%
Ovarian	4%	8%	11%	12%	2.9%	1.3%	2.9%
Bladder	7%	6%	11%	9%	2.4%	1.6%	0.8%
Bladder	8%	6%	10%	9%	1.6%	1.6%	0.8%
CCLE	9%	6%	4%	4%	4%	5%	3%
Lung adeno	8%	4%	1.7%	3%	0.4%	13%	1.7%
Melanoma	7%	7%	1.4%	10%	4%	0.7%	1%
Lung adeno	8%	4%	1.7%	3%	0%	12%	1.7%
Esophagus	9%	3%	5%	2.2%	2.7%	2.7%	1.6%
Ovarian	1.3%	4%	10%	7%	0.3%	1.3%	1.3%
Lung Squ	2.3%	6%	3%	4%	1.1%	3%	4%
Uterine	2.9%	6%	6%	7%	2.1%	2.9%	3%
Stomach	8%	1.7%	3%	5%	1.4%	3%	3%
Uterine	3%	6%	5%	7%	1.3%	3%	2.9%